The collaboration centers on Seligman Investments, the technology and healthcare-focused arm of Columbia Threadneedle. Managed by chief investment officer Paul Wick from Silicon Valley, the team oversees $48.2 billion in assets across hedge funds, mutual funds, and managed accounts. The addition of the healthcare strategy arrives just as the fund celebrates its third anniversary.
Investor interest in these specialized alternatives remains robust, with the combined strategies attracting more than $1 billion in inflows since the start of 2026. For Columbia Threadneedle, the deal serves as a cornerstone of its strategy to scale its global alternatives footprint through high-level wealth management partnerships across Asia, building on the momentum generated by previous technology-sector product launches.

Comments (0)
No comments yet. Be the first!